- Addition to ADM’s existing health and wellness capabilities creates fully integrated probiotics and nutraceuticals business for consumer and commercial markets
Archer Daniels Midland Company (NYSE: ADM) announced today that it has
reached an agreement to acquire Probiotics International Limited (PIL),
a U.K.-based provider of probiotic supplements for human, pet, and
production-animal use. The all-cash transaction will be valued at £185
million, subject to customary adjustments.
“ADM is already one of the world’s largest providers of human and animal
nutrition solutions, and the acquisition of PIL will add to our
extensive portfolio of products that promote health and wellness,” said
Vikram Luthar, president, ADM Health & Wellness. “We took a major step
in this area last year with the addition of Biopolis, and then added to
our capabilities with our personalized nutrition collaboration with Mayo
Clinic, our joint development agreement with Vland Biotech, and our new
enzyme lab in California. Now, with the addition of PIL’s extensive
sales and marketing network to our existing R&D capabilities, we are
building a world class, fully integrated probiotics and nutraceuticals
business.”
PIL, based in Somerset, U.K. — and known under its umbrella brand
Protexin — is a leading provider of probiotic supplements for human
wellness and animal markets, including aquaculture, equine, livestock
and companion animals. With sales into more than 60 countries, PIL
produces the popular Bio-Kult brand of probiotic supplements along with
contract-manufactured products. The company has about 160 employees.
“Early this year, we brought our wide range of animal and human
nutrition product lines together into a single Nutrition business unit,
with the goal of not just feeding the world, but also providing better
nutrition and improving the quality of life for consumers around the
globe,” said Vince Macciocchi, president of ADM’s Nutrition business
unit. “A key part of that integrated Nutrition platform is our Health &
Wellness business, which includes bioactives, botanical extracts and
specialty nutritional oils, including innovative products such as our
Onavita™ algal DHA oil, and Novatol® Vitamin E 1490PH. The addition of
PIL is just one of the many important investments we are making to grow
our entire integrated Nutrition business. From the growth of our
bioactives platform, to new Animal Nutrition facilities in North America
and China, to our expanding network of food and beverage ingredient
innovation centers, we are enhancing our presence in a growing market
and ensuring that we are the go-to provider for complete health and
wellness and ingredients solutions for human and animal nutrition
customers alike.”
“PIL has created market-leading brands in the veterinary, equine and
human health markets around the world, and we are delighted to join
ADM’s Health and Wellness business. We very much look forward to
building on this success,” said Jonathan Sowler, PIL commercial
director. “There are great synergies with ADM and Biopolis, especially
in the area of R&D, and we plan to add to an already very exciting
development pipeline to provide innovative, evidence-based products of
the highest quality for people and animals.”
The deal, which is subject to regulatory review, is expected to close in
the third quarter.
Forward-Looking Statements
Some of the above statements constitute forward-looking statements.
ADM’s filings with the SEC provide detailed information on such
statements and risks, and should be consulted along with this release.
To the extent permitted under applicable law, ADM assumes no obligation
to update any forward-looking statements.
About Probiotics International Ltd (Protexin Healthcare)
Protexin Healthcare is dedicated to producing innovative, research based
probiotic products of the highest quality for the healthcare market. The
natural supplements they manufacture are extensively researched for
safety and efficacy. Protexin works closely with leading universities
and research centres around the world on a range of on-going research
programmes. Every product produced by Protexin is manufactured in their
own purpose built, state-of-the-art facility in Somerset, U.K. All
products are subject to the same high standard of production and quality
control as pharmaceutical products and they hold the following
accreditations; cGMP (MHRA), ISO 9001:2008, FEMAS, VMD (category 5),
each of which involves regular audits to ensure standards are maintained.
Protexin has also been awarded The Queen’s Award for Enterprise in
International Trade in both 2011 and 2016 as well as a 2* Best Company
to work for in 2018.
About ADM
For more than a century, the people of Archer Daniels Midland Company
(NYSE: ADM) have transformed crops into products that serve the vital
needs of a growing world. Today, we’re one of the world’s largest
agricultural processors and food ingredient providers, with
approximately 31,000 employees serving customers in more than 170
countries. With a global value chain that includes approximately 500
crop procurement locations, 270 ingredient manufacturing facilities, 44
innovation centers and the world’s premier crop transportation network,
we connect the harvest to the home, making products for food, animal
feed, industrial and energy uses. Learn more at www.adm.com.
Archer Daniels Midland Company
Media Relations
Jackie Anderson
media@adm.com
312-634-8484